New pill aims to ease nerve pain after spinal cord injury
NCT ID NCT06438471
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This early-stage study tests whether a new drug called EC5026 is safe and can reduce nerve pain in people with spinal cord injury. About 36 adults with pain from traumatic or non-traumatic spinal cord injury will take either the drug or a placebo daily for 14 days. Researchers will monitor side effects and measure changes in pain, sleep, and daily function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AU Medical Center
RECRUITINGAugusta, Georgia, 30912, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could music be medicine for the injured brain?
- Can a skin injection of ketamine and lidocaine tame CRPS pain?
- Could painkillers quietly disrupt your hormones?
- Robots join the rehab team: a new hope for regaining movement?
- Alzheimer's drug may stop chronic pain after breast surgery
- Can a sugar pill curb the opioid crisis?